INDV compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

INDVIndivior Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

INDVIndivior Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

INDV

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.3%▲+1.38%×0.11

Q2 FY26—▼−6.60%—

Q1 FY26±12.8%▲+7.70%×0.60

Feb 26 '26±13.8%▲+0.24%×0.01

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedINDV realized, solidLLY realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

INDVIndivior Pharmaceuticals, Inc.

26.78▲+0.15%

Mkt cap$3.2BRevenue$356MQ3 FY26Revenue$1.2BFY25

LLYELI Lilly & Co

1,370.21▲+0.40%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

INDVIndivior Pharmaceuticals, Inc.

LLYELI Lilly & Co

26.78▲+0.15%

Price

1,370.21▲+0.40%

$3.2B

Mkt cap

$1.2T

Q3 FY26$356M

Revenue

$24.4BQ3 FY26

FY25$1.2B

Revenue

$65.2BFY25

INDV26.78▲+0.15%vsLLY1,370.21▲+0.40%Regular sessionNov 6 '26